Dr. Reddy’s launches novel molecule ‘Tegoprazan’ in India
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
The study further confirmed that GAL-101 effectively crosses the blood-brain barrier
Argo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographies and potential near-term equity
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Establishing Asymchem’s first manufacturing footprint in Europe
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
Subscribe To Our Newsletter & Stay Updated